Best Warren Buffett Stocks To Own Right Now

The Financial Industry Regulatory Authority filed on Monday a proposal to provide more transparency in the estimated per-share value of unlisted direct participation programs and real estate investment trusts.

FINRA’s proposal, filed with the Securities and Exchange Commission, would eliminate the broker-dealer practice of listing the value of nontraded REITs at $10 per share. The rule change would require BDs to factor in fees and commissions paid to them when determining the estimated share value, which would mean lower share prices.  

FINRA proposes two methodologies under which an estimated share value would be presumed reliable: net investment and independent valuation.

The Investment Program Association, which represents nonlisted direct investment vehicles, said in a statement that it “worked tirelessly” with FINRA to revise the existing customer account statement rule “to enhance transparency and provide investors with a clearer picture of nonlisted REITs and Direct Participation Programs as they evolve.”

Best Warren Buffett Stocks To Own Right Now: Exelixis Inc.(EXEL)

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Selena Maranjian]

    Companies that stand a good chance of surging in coming years are also good Roth candidates. Exelixis (NASDAQ: EXEL  ) , for example, is a smallish biotech company tackling various cancers. It even has an approved thyroid cancer drug on the market, and the formula may end up approved to treat other conditions, as well. The downside, though, is that the drug is expensive, and the segment of thyroid-cancer patients who might take it is very small.

  • [By Sean Williams]

    Where investment dollars are headed
    Thyroid cancer is treated in nearly every case with a full or partial thyroid removal since the majority of thyroid cancers aren’t aggressive. However, in those rare cases where surgery isn’t an option or the disease has metastasized to other parts of the body, there are two drugs approved by the Food and Drug Administration to choose from.

    Caprelsa: AstraZeneca’s (NYSE: AZN  ) Caprelsa was approved to treat unresectable, locally advanced, or metastatic medullary thyroid cancer in April 2011. In trials, AstraZeneca’s pill increased progression-free survival over the placebo and delivered an overall response rate of 44%, compared with just 1% for the placebo — although it should be noted that all responses were partial. However, Caprelsa also comes with a laundry list of side effects that range from something as simple as rash, nausea, and hypertension, to having resulted in death from respiratory arrest and cardiac failure with arrhythmia.  Cometriq: Exelixis’ (NASDAQ: EXEL  ) Cometriq was approved last November to treat progressive metastatic medullary thyroid cancer. The capsules work by inhibiting multiple tyrosine kinases, which are crucial to blood vessel growth in solid and metastasizing tumors. In late-stage trials, patients receiving Cometriq demonstrated an astounding 11.2 months of progression-free survival compared with just four months for the placebo. Further, the objective response rate was 27% in the Cometriq arm and a goose egg for the placebo arm. Similar to AstraZeneca’s Caprelsa, severe adverse reactions tended to increase for Cometriq users relative to the placebo.

    Just as we’ve witnessed with every previous cancer in this series, not every drug trial proves successful. Pfizer’s (NYSE: PFE  ) Sutent, for instance, is a very successful treatment for kidney cancer, gastrointestinal stromal tumors, and pancreatic endocrine tumors, but it didn’t fare as wel

  • [By Selena Maranjian]

    The biggest new holdings are The Finish Line and Aeropostale. Other new holdings of interest include biotech company Exelixis (NASDAQ: EXEL  ) , which received FDA approval last year for its thyroid cancer drug, Cometriq. The drug may also get approved to treat prostate cancer, and the company is looking at treating as many as nine different cancers with it. On the other hand, Cometriq is expensive, and the company’s debt has been growing, along with its share count.

  • [By Sean Williams]

    Exelixis (NASDAQ: EXEL  )
    Yesterday was a big day for Exelixis shareholders, as it gave them their first glimpse of Cometriq sales. Designed for the treatment of metastatic medullary thyroid cancer, or MTC — a rare but particularly aggressive form of thyroid cancer — Cometriq, which is Exelixis’ first drug approved by the Food and Drug Administration, nearly tripled progression-free survival in trials relative to AstraZeneca’s (NYSE: AZN  ) Caprelsa, the current standard of treatment (11.2 months compared to four months). Based on those stats alone, I expect Cometriq to take practically all sales from AstraZeneca in MTC.

Best Warren Buffett Stocks To Own Right Now: MSCI Inc (MSCI)

MSCI Inc., together with its subsidiaries, provides a suite of performance, risk management, and corporate governance products and services worldwide. The company operates in two segments, Performance and Risk, and Governance. The Performance and Risk segment offers investment decision support tools, including equity indices, real estate indices and benchmarks, portfolio risk and performance analytics, and credit analytics, as well as environmental, social, and governance products. Its products are used in various investment processes, including portfolio construction and rebalancing, performance benchmarking and attribution, risk management and analysis, regulatory and client reporting, index-linked investment product creation, asset allocation, social responsibility assessment, environmental stewardship, investment manager selection, and investment research. The Governance segment provides corporate governance products and services, and specialized financial research and analysis services to institutional investors and corporations. It facilitates the voting of proxies by institutional investors and provides in-depth research and analysis to help inform voting decisions and identify issuer-specific risk; and offers global equity security coverage, and integrated products and services, including proxy voting, policy creation, research, vote recommendations, vote execution, post-vote disclosure, and reporting and analytical tools. This segment also provides class action monitoring and claims filing services to aid institutional investors in the recovery of funds from securities class action settlements. The company offers its products and services under the MSCI, MSCI ESG, Barra, RiskMetrics, ISS, FEA, IPD, and CFRA brands. Its clients include asset owners, institutional and retail asset managers, and financial intermediaries. The company was founded in 1998 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Benjamin Shepherd]

    The iShares MSCI Emerging Markets Index (NYSE: EEM) seems to have halted its slide.  The index bottomed out year-to-date on February 3, when it was down 11.2 percent. Since then, it has gained 1.5 percent, but bargains in the emerging markets still abound.

    As I discussed in “A Plan, Not a Panic” two weeks ago, emerging markets are in much better economic shape today than they were even just a few years ago, much less during the currency crisis that peaked in 1998. Foreign exchange reserves are generally much more robust, budget deficits are narrower if they exist at all and, so far at least, the full-blown currency war that many were predicting last year isn’t likely to breakout.

    With rationality finally setting in, this is a terrific time to do a little bargain hunting in the emerging markets.

    The most obvious play here is the iShares MSCI Emerging Markets Index itself. Covering China (18.8 percent of assets), South Korea (16 percent), Taiwan ( 12 percent) and Brazil (10.2 percent) with smaller positions spanning Asia and Europe, the fund is most exposed to any shift in sentiment.

    The fund is currently trading at just 10.2 times forward one-year earnings, well below its average of about 18 times over the past two decades. On a price-to-sales basis it is even more attractive valued at just 1.03 times; the last time the index was this cheap on a sales basis was early 2009.

    So while there are always dangers in trying to call a bottom to any market move, valuations alone are attractive enough to start pulling bargain hunters back in.

    A broadly diversified play on an emerging market turnaround, iShares MSCI Emerging Markets Index is a great buy up to 45, which leaves plenty of room to run back to the average.

    For those who can tolerate a bit more risk, you can also drill down and make more country-specific bets.

    At this point my favorite would be iShares MSCI South Korea Index Fund (NY SE: EWY).

    Sout

Best Warren Buffett Stocks To Own Right Now: Beam Inc (BEAM)

Beam Inc. (Beam), incorporated on October 1, 1985, is a premium spirits company that makes and sells branded distilled spirits products in markets worldwide. The Company’s principal products include bourbon whiskey, tequila, Scotch whisky, Canadian whisky, vodka, cognac, rum, cordials, and ready-to-drink pre-mixed cocktails. The Company’s portfolio consists of brands the Company identifies as Power Brands, Rising Stars, Local Jewels and values Creators. The Power Brands are the Company’s core brand equities, with global reach in premium categories. Rising Stars are smaller premium brands. Brands identified as Local Jewels act as Power Brands in local markets. Value Creators include a variety of brands. The Company’s three reportable segments are the geographic regions, which consists of North America, Europe/Middle East/Africa (EMEA), and Asia-Pacific/South America (APSA). Each segment is engaged in the manufacture and sale of distilled spirits products. In May 2012, the C ompany acquired the Pinnacle vodka and Calico Jack rum brands and certain related assets (Pinnacle assets) from White Rock Distilleries, Inc. In January 2012, Beam acquired Cooley Distillery plc (Cooley), an Irish whiskey producer.

The Company’s Power Brands include Jim Beam Bourbon, Maker’s Mark Bourbon, Sauza Tequila, Courvoisier Cognac, Canadian Club Whisky, Teacher’s Scotch and Pinnacle Vodka. Beam’s Rising Stars brand includes Laphroaig Scotch, Knob Creek Bourbon, Basil Hayden’s Bourbon, Kilbeggan Irish Whiskey, Cruzan Rum, Hornitos Tequila, Skinnygirl Cocktails and Sourz Liqueurs. The principal markets for the Company’s spirits products are the United States, Australia, Germany, Spain, the United Kingdom, and Canada, and the Company continues to invest in emerging markets such as India, Brazil, Mexico, Russia, Central Europe, Asia, and other geographies.

During the year ended December 31, 2012, Power Brands, Rising Stars, and combined Loc al Jewels/Value Creators (including non-branded sales) repre! sent approximately 60%, 15%, and 25%, respectively, of the Company’s net sales. Approximately 55% of its consolidated net sales were generated in the United States (based on country of destination) during 2012. In the United States, the Company sells its products either to wholesale distributors for resale to retail outlets or, in those states that control alcohol sales, to state governments who then sell them to retail customers and consumers. In the Company’s other global markets, the Company uses a variety of route-to-market models, including third party distributors, global or regional duty free customers, other spirits producers and its joint ventures with The Edrington Group Ltd.

The Company competes with Bacardi Limited, Brown-Forman Corporation, Constellation Brands, Inc., Davide Campari Milano-S.p.A., Diageo PLC, Pernod Ricard S.A. and Remy Cointreau S.A.

Advisors’ Opinion:

  • [By Patricio Kehoe]

    When Diageo’s CEO Ivan Menezes declared last quarter that the company would not be buying Beam Inc. (BEAM) in order to boost its bourbon and tequila portfolio, it became clear that the firm was well off as it is. And I applaud management’s decision to hold back, because this firm’s unmatched spirit portfolio combined with its vast distribution network make it a solid global market leader. Although the company operates in 180 countries, its particularly strong position in the U.S. market is highly beneficial, as this is the most profitable spirits market worldwide. The distribution, handled by 2,800 exclusive salespeople that only attend the company’s namesake brands, is highly profitable, resulting in domestic operating margins of almost 40%. Also, these distributor relationships cover 80% of the company’s U.S. volume, making for a business model that would be very difficult for new market entrants to duplicate.

  • [By Anna Prior]

    Beam Inc.(BEAM) said that federal antitrust regulators have given clearance for the spirits company’s takeover by Suntory Holding Ltd. Beam said Wednesday that the U.S. Federal Trade Commission has granted early termination of the necessary waiting period to review Beam’s proposed acquisition by Suntory.

Best Warren Buffett Stocks To Own Right Now: Harbinger Group Inc (HRG)

Harbinger Group Inc. (HGI), incorporated on November 3, 2009, is a holding company. The Company’s operations are conducted through Spectrum Brands, the Company’s subsidiary, which provides branded consumer products, such as batteries, personal care products, small household appliances, pet supplies, and home and garden pest control products, and Fidelity & Guaranty Life Holdings, Inc. (FGL), its wholly owned indirect subsidiary, which provides life insurance and annuity products. In addition, Salus Capital Partners, LLC (Salus), the Company’s wholly owned indirect subsidiary, is engaged in the business of providing secured asset-based loans across a range of industries, and Front Street Re Ltd (Front Street), its wholly owned indirect subsidiary provide reinsurance to the specialty insurance sector of fixed, deferred and payout annuities. The Company also own 97.9% of Zap.Com Corporation (Zap.Com), a public shell company, which may seek assets or businesses to acquire or m ay sell assets and/or liquidate. On November 8, 2012, Spectrum Brands completed acquisition of 56% interest in Shaser Biosciences, Inc.

Spectrum Brands

Spectrum Brands Holdings, Inc. is a global branded consumer products company. As of September 30, 2012, HGI owns approximately 57.4% of Spectrum Brands. Spectrum Brands manufactures and markets alkaline, zinc carbon and hearing aid batteries, herbicides, insecticides and repellents and specialty pet supplies. Spectrum Brands also designs and markets rechargeable batteries, battery-powered lighting products, electric shavers and accessories, grooming products and hair care household appliances. In addition, Spectrum Brands designs, markets and distributes a broad range of branded small appliances and personal care products. Spectrum Brands’ manufacturing and product development facilities are located in the United States, Europe, Latin America and Asia. Spectrum Brands’ rechargeable batteries and char gers, shaving and grooming products, small household applian! ces, personal care products and portable lighting products are manufactured by third-party suppliers, located in Asia.

Spectrum Brands sells products in approximately 140 countries through a range of trade channels, including retailers, wholesalers and distributors, hearing aid professionals, industrial distributors and original equipment manufacturers (OEMs). Spectrum Brands’ branded consumer products have positions in six product categories: consumer batteries; small appliances; pet supplies; home and garden control products; electric shaving and grooming products, and electric personal care products. Spectrum Brands competes in six product categories: consumer batteries, small appliances, pet supplies, home and garden control products, electric shaving and grooming, and electric personal care products. Spectrum Brands’ range of products include consumer batteries, including alkaline and zinc carbon batteries, rechargeable batteries and chargers and hearing ai d batteries, other specialty batteries and portable lighting products; small appliances, including small kitchen appliances and home product appliances; pet supplies, including aquatic equipment and supplies, dog and cat treats, small animal foods, clean up and training aids, health and grooming products and bedding; home and garden control products, including household insect controls, insect repellents and herbicides; electric shaving and grooming devices, and electric and wet personal care and styling devices.

Spectrum Brands markets and sells a range of alkaline batteries to both retail and industrial customers. Spectrum Brands’ alkaline batteries are marketed and sold under the Rayovac and VARTA brands. Spectrum Brands also manufactures alkaline batteries for third parties who sell the batteries under their own private labels. Spectrum Brands’ zinc carbon batteries are also marketed and sold under the Rayovac and VARTA brands. Spectrum Brands sells its hea ring aid batteries through retail trade channels and directl! y to prof! essional audiologists under brand names and private labels, including Beltone, Miracle Ear and Starkey. Spectrum Brands also sells Nickel Metal Hydride (NiMH) rechargeable batteries and a range of battery chargers under the Rayovac and VARTA brands. Spectrum Brands’ other specialty battery products include camera batteries, lithium batteries, silver oxide batteries, keyless entry batteries and coin cells for use in watches, cameras, calculators, communications equipment and medical instruments. Spectrum Brands offers a range of battery-powered, portable lighting products, including flashlights and lanterns for both retail and industrial markets. Spectrum Brands sells its portable lighting products under the Rayovac and VARTA brand names, under other brand names and pursuant to licensing arrangements with third parties.

Spectrum Brands markets and sells a range of products in the branded small household appliances category under the George Foreman, Black & Decke r, Russell Hobbs, Farberware, Juiceman, Breadman and Toastmaster brands, including grills, bread makers, sandwich makers, kettles, toaster ovens, toasters, blenders, juicers, can openers, coffee grinders, coffeemakers, electric knives, deep fryers, food choppers, food processors, hand mixers, rice cookers and steamers. Spectrum Brands also markets small home product appliances, including hand-held irons, vacuum cleaners, air purifiers, clothes shavers and heaters, primarily under the Black & Decker and Russell Hobbs brands.

In the pet supplies product category Spectrum Brands markets and sells a range of branded pet supplies for fish, dogs, cats, birds and other small domestic animals. Spectrum Brands has a range of consumer and commercial aquatics products, including integrated aquarium kits, standalone tanks and stands, filtration systems, heaters, pumps, and other equipment, fish food and water treatment products. Spectrum Brands’ aquatics brands are Tetra, M arineland, Whisper, Jungle and Instant Ocean. Spectrum Brand! s also se! lls a range of specialty pet products, including dog and cat treats, small animal food and treats, clean up and training aid products, health and grooming aids, bedding products and consumable accessories including privacy tents, litter carpets, crystal litter cartridges, charcoal filters, corn-based litter and replaceable waste receptacles. Spectrum Brands’ specialty pet brands include FURminator, 8-in-1, Dingo, Firstrax, Nature’s Miracle, Wild Harvest and Littermaid.

In the home and garden control products category Spectrum Brands markets and sells home and garden care products, including household insecticides, insect repellent, herbicides, garden and indoor plant foods and plant care treatments. Spectrum Brands offers a range of household insecticides, such as spider, roach and ant killer, flying insect killer, insect foggers, wasp and hornet killer, flea and tick control products and roach and ant baits. Spectrum Brands also manufactures and markets a range of insect repellent products, which provide protection from insects, especially mosquitoes. These products include both personal repellents, such as aerosols, pump sprays and wipes, as well as area repellents, such as yard sprays, citronella candles and torches. Spectrum Brands’ brands in the insect control category include Hot Shot, Cutter, Repel, Black Flag and TAT. Spectrum Brands’ herbicides brands include Spectracide, Real-Kill and Garden Safe. Spectrum Brands markets and sells a range of electric shaving and grooming products under the Remington brand name, including men’s rotary and foil shavers, beard and mustache trimmers, body trimmers and nose and ear trimmers, women’s shavers and haircut kits. Spectrum Brands’ electric personal care products, marketed and sold under the Remington, Russell Hobbs, Carmen and Andrew Collinge brand names, include hand-held dryers, curling irons, straightening irons, brush irons, hair setters, facial brushes, skin appliances and elec tric toothbrushes.

FGL

FGL is an i! ndirectly! wholly owned subsidiary of HGI, is a provider of annuity and life insurance products in the United States. Based in Baltimore, Maryland, FGL operates its annuity and life insurance operations in the United States through its subsidiaries FGL Insurance and FGL NY Insurance. FGL’s products are annuities, deferred annuities and life insurance products (including fixed indexed universal life), which it sells, as of September 30, 2012, through a network of approximately 200 insurance marketing organizations (IMOs) representing approximately 19,000 independent agents and managing general agents. As of September 30, 2012, FGL had over 713,000 policyholders nationwide and distributes its products throughout the United States.

FGL’s deferred annuities include fixed index annuities and fixed rate annuities. Fixed rate annuities include annual reset and multi-year rate guaranteed policies. FGL, through its insurance subsidiaries, issues a range of deferred annuities (fixe d indexed and fixed rate annuities) and immediate annuities. Fidelity & Guaranty Life Insurance Company’s (FGL Insurance’s) fixed indexed annuities allow contract owners the possibility of earning credits based on the performance of a specified market index without risk to principal. The contracts include a provision for a minimum guaranteed surrender value calculated in accordance with applicable law. During the year ended September 30, 2012 (fiscal 2012), approximately 96% of the fixed indexed annuity sales involved premium bonuses. Fixed rate annuities include annual reset and multi-year rate guaranteed policies. Fixed rate annual reset annuities issued by FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York (FGL NY Insurance) have an annual interest rate. FGL Insurance and FGL NY Insurance also sell single premium immediate annuities (SPIAs), which provide a series of periodic payments for a fixed period of time or for the life of the policyholder. FG L Insurance and FGL NY Insurance offer indexed universal lif! e insuran! ce policies. Holders of universal life insurance policies earn returns on their policies which are credited to the policyholder’s cash value account.

In addition to services provided by third-party asset managers, FGL outsources the following functions to third-party service providers, including investment accounting and custody, and underwriting administration of life insurance applications. FGL manages its outsourcing partners and integrates their services into its operations. FGL outsources its new business and existing policy administration for fixed indexed annuity and life products to Transaction Applications Group, Inc., a subsidiary at Dell Inc. (Transaction Group). Under this arrangement, Transaction Group manages all of FGL’s call center and processing requirements. FGL has partnered with Hooper Holmes, Inc. (Hooper Holmes) to outsource its life insurance underwriting function. FGL, through its subsidiary FGL Insurance, both cedes reinsurance to othe r insurance companies and assumes reinsurance from other insurance companies. FGL Insurance provides reinsurance as the reinsurer to four non-affiliate insurance companies.

Salus

Salus, an indirectly wholly owned subsidiary of HGI, is a provider of secured asset-based loans to the middle market across a range of industries with financing throughout the capital structure. The Salus platform also serves as an asset manager to certain institutional investors, such as community and regional banks, insurance companies, family offices, private equity funds and hedge funds who may lack the infrastructure and dedicated competency within senior secured lending. Salus provides secured asset-based loans to the middle market. Salus focuses its credit analysis on the value of accounts receivable and inventory (or other assets) and estimates how much liquidity it can provide against those assets. Salus’ loans are used across a range of industries for general wor king capital or seasonal needs, acquisitions or opportunisti! c situati! ons, trade finance, turnarounds, dividend recaps, refinancing and debtor-in-possession financing.

The Company competes with Energizer Holdings, Inc. (Energizer), The Procter & Gamble Company, Matsushita , Energizer and Mag Instrument, Inc., Mars Corporation, The Hartz Mountain Corporation, Central Garden & Pet Company, The Scotts Miracle-Gro Company, Bayer A.G., S.C. Johnson & Son, Inc., Scotts Company, Henkel KGaA, Koninklijke Philips Electronics NV, Jarden Corporation, DeLonghi America, Euro-Pro Operating LLC, Metro Thebe, Inc., d/b/a HWI Breville, NACCO Industries, Inc., SEB S.A., Conair Corporation, Wahl Clipper Corporation and Helen of Troy Limited.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Harbinger Group (NYSE: HRG  ) , whose recent revenue and earnings are plotted below.

Best Warren Buffett Stocks To Own Right Now: Dean Foods Company(DF)

Dean Foods Company, together with its subsidiaries, operates as a food and beverage company in the United States. It operates in two segments, Fresh Dairy Direct-Morningstar and WhiteWave-Alpro. The Fresh Dairy Direct-Morningstar segment manufactures, markets, and distributes various branded and private label dairy case products, including cream, ice cream mix, and ice cream novelties; creamers and other extended shelf life fluids; yogurt, cottage cheeses, sour creams, and dairy-based dips; fruit juices, fruit-flavored drinks, iced teas, and water; half-and-half and whipping creams; and items for resale, such as butter, cheese, eggs, and milk shakes. This segment sells its dairy case products to retailers, distributors, foodservice outlets, educational institutions, and governmental entities. The WhiteWave-Alpro segment manufactures, develops, markets, and sells various branded dairy and dairy-related products, such as milk and other dairy products; organic dairy products; plant-based beverages, such as soy, almond, and coconut milks; and soy food products, coffee creamers, and creamers and fluid dairy products. It also provides branded soy-based beverages and food products in Europe under the Alpro and Provamel brands. This segment sells its products to various customers, including grocery stores, club stores, natural foods stores, mass merchandisers, convenience stores, drug stores, and foodservice outlets. The company was formerly known as Suiza Foods Corporation and changed its name to Dean Foods Company on December 21, 2001 as a result of merger between the former Dean Foods Company and Suiza Foods Corporation. Dean Foods Company was founded in 1995 and is headquartered in Dallas, Texas.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Get ready for rotten food stocks today. Dean Foods (DF) has fallen 11% to $13.50 after it met earnings expectations but said the first quarter of 2014 would be “difficult.” Annie’s (BNNY), meanwhile, has dropped 8.7% to $38.19 after it missed earnings forecasts and offered a disappointing 2014 outlook. ConAgra Foods (CAG) has declined 5.5% to $29.35, after it too cut its full year guidance.

  • [By Jacob Roche]

    It’s clear that this isn’t just a problem with the grocery stores themselves. Dean Foods (NYSE: DF  ) , essentially the Pinnacle Foods of milk products, had flat sales growth from 2007 to 2011, just like conventional grocers. White Wave Foods, Dean’s former organic milk subsidiary and recent spinoff, had impressive 64% growth during that time.